头颈癌患者呼吸与肺部并发症:COVID-19时代的循证综述
该综述评估头颈鳞状细胞癌(HNSCC)患者肺部并发症与不良呼吸结局的影响。高龄、吸烟饮酒史及心肺合并症是显著危险因素,放疗或放化疗毒性显著增加风险。呼吸并发症是HNSCC患者发病和死亡的常见原因,COVID-19大流行可能对此人群造成更大影响。
要点
- 高龄、吸烟饮酒史及心肺合并症是HNSCC患者不良呼吸结局的显著危险因素。
- 放疗或放化疗毒性显著增加HNSCC患者呼吸系统风险。
- 呼吸并发症是HNSCC患者发病和死亡的常见原因,COVID-19可能加重负担。
核心结论
- 呼吸并发症是HNSCC患者发病和死亡的常见原因,COVID-19大流行可能对此人群造成更大影响。
研究设计与样本
- 范围综述(scoping review),评估HNSCC患者肺部合并症与不良呼吸结局的影响。
主要发现
- 高龄、吸烟饮酒史及心肺合并症是HNSCC患者发生不良呼吸结局的显著危险因素。
- 放疗或放化疗的治疗毒性显著增加HNSCC患者呼吸系统风险。
临床怎么用
- 通过减少吸烟饮酒、改善口腔卫生及积极管理内科合并症,有助于HNSCC患者的长期管理和健康。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Pulmonary complications and infections frequently affect patients with head and neck squamous cell carcinoma (HNSCC). Common characteristics can predispose these patients to the development of severe respiratory illness, which may be particularly relevant during the 2019 coronavirus disease (COVID-19) pandemic. METHODS: A scoping review was performed to assess the impact of pulmonary comorbidities and adverse respiratory outcomes in HNSCC patients. RESULTS: Advanced age, history of tobacco and alcohol abuse, and cardiopulmonary comorbidities are significant risk factors for the development of adverse respiratory outcomes. Treatment toxicities from radiation or chemoradiation therapy significantly increase these risks. CONCLUSION: Respiratory complications are a frequent cause of morbidity and mortality among HNSCC patients, and the COVID-19 pandemic may disproportionately affect this population. Interventions designed to decrease smoking and alcohol use, improve oral hygiene, and aggressively manage medical comorbidities are important to the long-term management and health of these patients.
引用
- Silverman DA, Lin C, Tamaki A, et al. Respiratory and pulmonary complications in head and neck cancer patients: Evidence-based review for the COVID-19 era. Head Neck. 2020. PMID: 32343013. doi:10.1002/hed.26217
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。